These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 9198232

  • 1. Analysis of factor VIII inhibitors using hybrid human/porcine factor VIII.
    Lollar P.
    Thromb Haemost; 1997 Jul; 78(1):647-51. PubMed ID: 9198232
    [Abstract] [Full Text] [Related]

  • 2. Mapping factor VIII inhibitor epitopes using hybrid human/porcine factor VIII molecules.
    Lollar P.
    Haematologica; 2000 Oct; 85(10 Suppl):26-8; discussion 28-30. PubMed ID: 11187866
    [Abstract] [Full Text] [Related]

  • 3. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA, Levin LG, Harrison JA, DePianto DJ, Suzuki CM, Ziaja CL, Brown JE, Jolly KW, Reisner HM, Abildgaard CF, Powell JS.
    Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the human factor VIII A2 inhibitor epitope by alanine scanning mutagenesis.
    Lubin IM, Healey JF, Barrow RT, Scandella D, Lollar P.
    J Biol Chem; 1997 Nov 28; 272(48):30191-5. PubMed ID: 9374501
    [Abstract] [Full Text] [Related]

  • 5. Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia A patients with factor VIII inhibitor.
    Sugihara T, Takahashi I, Kojima T, Okamoto Y, Yamamoto K, Kamiya T, Matsushita T, Saito H.
    Nagoya J Med Sci; 2000 May 28; 63(1-2):25-39. PubMed ID: 10911718
    [Abstract] [Full Text] [Related]

  • 6. Residues 484-508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII.
    Healey JF, Lubin IM, Nakai H, Saenko EL, Hoyer LW, Scandella D, Lollar P.
    J Biol Chem; 1995 Jun 16; 270(24):14505-9. PubMed ID: 7540171
    [Abstract] [Full Text] [Related]

  • 7. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
    Shima M, Scandella D, Yoshioka A, Nakai H, Tanaka I, Kamisue S, Terada S, Fukui H.
    Thromb Haemost; 1993 Mar 01; 69(3):240-6. PubMed ID: 7682339
    [Abstract] [Full Text] [Related]

  • 8. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.
    Kopecky EM, Greinstetter S, Pabinger I, Buchacher A, Römisch J, Jungbauer A.
    J Immunol Methods; 2006 Jan 20; 308(1-2):90-100. PubMed ID: 16376372
    [Abstract] [Full Text] [Related]

  • 9. Humoral immune responsiveness to a defined epitope on factor VIII before and after B cell ablation with rituximab.
    Kessel C, Königs C, Linde R, Escuriola-Ettinghausen C, Stoll H, Klingebiel T, Dietrich U, Kreuz W.
    Mol Immunol; 2008 Nov 20; 46(1):8-15. PubMed ID: 18715645
    [Abstract] [Full Text] [Related]

  • 10. Human anti-factor VIII antibodies: epitope localization and inhibitory function.
    Scandella D.
    Vox Sang; 1996 Nov 20; 70 Suppl 1():9-14. PubMed ID: 8869462
    [Abstract] [Full Text] [Related]

  • 11. Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII.
    Healey JF, Barrow RT, Tamim HM, Lubin IM, Shima M, Scandella D, Lollar P.
    Blood; 1998 Nov 15; 92(10):3701-9. PubMed ID: 9808564
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A soluble recombinant factor VIII fragment containing the A2 domain binds to some human anti-factor VIII antibodies that are not detected by immunoblotting.
    Scandella D, Timmons L, Mattingly M, Trabold N, Hoyer LW.
    Thromb Haemost; 1992 Jun 01; 67(6):665-71. PubMed ID: 1509407
    [Abstract] [Full Text] [Related]

  • 14. Induction of human factor VIII inhibitors in rats 2: Fine mapping of rat anti-human rFVIII antibodies.
    Levin LG, Jarvis M, Powell J, Harrison JA, Reisner HM.
    Thromb Haemost; 1996 Dec 01; 76(6):998-1003. PubMed ID: 8972024
    [Abstract] [Full Text] [Related]

  • 15. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S, Sharifian RA, Khoshnoodi J, Karimi K, Milani M, Okita DK, Shokri F, Conti-Fine BM.
    Thromb Haemost; 2009 May 01; 101(5):834-9. PubMed ID: 19404535
    [Abstract] [Full Text] [Related]

  • 16. Factor VIII inhibitors.
    Gilles JG, Jacquemin MG, Saint-Remy JM.
    Thromb Haemost; 1997 Jul 01; 78(1):641-6. PubMed ID: 9198231
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Longitudinal analysis of factor VIII inhibitors in a previously untreated mild haemophilia A patient with an Arg593-->Cys substitution.
    van den Brink EN, Timmermans SM, Turenhout EA, Bank CM, Fijnvandraat K, Voorberg J, Peters M.
    Thromb Haemost; 1999 May 01; 81(5):723-6. PubMed ID: 10365744
    [Abstract] [Full Text] [Related]

  • 19. Immunobiology of inhibitor development in hemophilia A.
    Fijnvandraat K, Bril WS, Voorberg J.
    Semin Thromb Hemost; 2003 Feb 01; 29(1):61-8. PubMed ID: 12640567
    [Abstract] [Full Text] [Related]

  • 20. Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules.
    Barrow RT, Healey JF, Gailani D, Scandella D, Lollar P.
    Blood; 2000 Jan 15; 95(2):564-8. PubMed ID: 10627463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.